Process speeds up FDA approval for drugs that reflect Trump priorities. Watchdogs say program may hand out political favors more than advance public health
The research organization, launched two years ago, drew top talent. But its ability to churn out startups depended on more funding
As neural organoids grow more complex, scientists and ethicists urge oversight of research with these 3D structures made from human cells
